List of Tables
Table 1. Lung Disease Therapeutic Drug Market Trends
Table 2. Lung Disease Therapeutic Drug Market Drivers & Opportunity
Table 3. Lung Disease Therapeutic Drug Market Challenges
Table 4. Lung Disease Therapeutic Drug Market Restraints
Table 5. Global Lung Disease Therapeutic Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Disease Therapeutic Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Lung Disease Therapeutic Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Lung Disease Therapeutic Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Lung Disease Therapeutic Drug Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Lung Disease Therapeutic Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Lung Disease Therapeutic Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Lung Disease Therapeutic Drug
Table 13. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Lung Disease Therapeutic Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Lung Disease Therapeutic Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Lung Disease Therapeutic Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Lung Disease Therapeutic Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Lung Disease Therapeutic Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Lung Disease Therapeutic Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Lung Disease Therapeutic Drug Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Lung Disease Therapeutic Drug Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Lung Disease Therapeutic Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Lung Disease Therapeutic Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Lung Disease Therapeutic Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Lung Disease Therapeutic Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Lung Disease Therapeutic Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Lung Disease Therapeutic Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Lung Disease Therapeutic Drug Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Lung Disease Therapeutic Drug Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Lung Disease Therapeutic Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Lung Disease Therapeutic Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Lung Disease Therapeutic Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Lung Disease Therapeutic Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Lung Disease Therapeutic Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Lung Disease Therapeutic Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Lung Disease Therapeutic Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Lung Disease Therapeutic Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Lung Disease Therapeutic Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Lung Disease Therapeutic Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Lung Disease Therapeutic Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Lung Disease Therapeutic Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Lung Disease Therapeutic Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Lung Disease Therapeutic Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Lung Disease Therapeutic Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Lung Disease Therapeutic Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Lung Disease Therapeutic Drug Sales Volume, (2025-2030) & (K Units)
Table 57. GSK Company Information
Table 58. GSK Introduction and Business Overview
Table 59. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. GSK Lung Disease Therapeutic Drug Product Offerings
Table 61. GSK Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Introduction and Business Overview
Table 64. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. AstraZeneca Lung Disease Therapeutic Drug Product Offerings
Table 66. AstraZeneca Recent Development
Table 67. Boehringer Ingelheim Company Information
Table 68. Boehringer Ingelheim Introduction and Business Overview
Table 69. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Boehringer Ingelheim Lung Disease Therapeutic Drug Product Offerings
Table 71. Boehringer Ingelheim Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Lung Disease Therapeutic Drug Product Offerings
Table 76. Novartis Recent Development
Table 77. Mylan Company Information
Table 78. Mylan Introduction and Business Overview
Table 79. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Mylan Lung Disease Therapeutic Drug Product Offerings
Table 81. Mylan Recent Development
Table 82. Vertex Pharmaceuticals Company Information
Table 83. Vertex Pharmaceuticals Introduction and Business Overview
Table 84. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Offerings
Table 86. Vertex Pharmaceuticals Recent Development
Table 87. F. Hoffman La Roche Company Information
Table 88. F. Hoffman La Roche Introduction and Business Overview
Table 89. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. F. Hoffman La Roche Lung Disease Therapeutic Drug Product Offerings
Table 91. F. Hoffman La Roche Recent Development
Table 92. Teva Pharmaceuticals Company Information
Table 93. Teva Pharmaceuticals Introduction and Business Overview
Table 94. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Offerings
Table 96. Teva Pharmaceuticals Recent Development
Table 97. Cipla Company Information
Table 98. Cipla Introduction and Business Overview
Table 99. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Cipla Lung Disease Therapeutic Drug Product Offerings
Table 101. Cipla Recent Development
Table 102. Fibrogen Company Information
Table 103. Fibrogen Introduction and Business Overview
Table 104. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Fibrogen Lung Disease Therapeutic Drug Product Offerings
Table 106. Fibrogen Recent Development
Table 107. Liminal Biosciences Company Information
Table 108. Liminal Biosciences Introduction and Business Overview
Table 109. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Liminal Biosciences Lung Disease Therapeutic Drug Product Offerings
Table 111. Liminal Biosciences Recent Development
Table 112. PharmAkea Therapeutics Company Information
Table 113. PharmAkea Therapeutics Introduction and Business Overview
Table 114. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Offerings
Table 116. PharmAkea Therapeutics Recent Development
Table 117. IQVIA Company Information
Table 118. IQVIA Introduction and Business Overview
Table 119. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. IQVIA Lung Disease Therapeutic Drug Product Offerings
Table 121. IQVIA Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Lung Disease Therapeutic Drug Downstream Customers
Table 125. Lung Disease Therapeutic Drug Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Disease Therapeutic Drug Product Picture
Figure 2. Global Lung Disease Therapeutic Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Lung Disease Therapeutic Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global Lung Disease Therapeutic Drug Sales Price (2019-2030) & (US$/Unit)
Figure 6. Lung Disease Therapeutic Drug Report Years Considered
Figure 7. Global Lung Disease Therapeutic Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Lung Disease Therapeutic Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Disease Therapeutic Drug Revenue in 2023
Figure 10. Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Corticosteroids Picture
Figure 12. Bronchodilator Medications Picture
Figure 13. Mucolytics Picture
Figure 14. Antimicrobial Medications Picture
Figure 15. Others Picture
Figure 16. Global Lung Disease Therapeutic Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Lung Disease Therapeutic Drug Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Lung Disease Therapeutic Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Lung Disease Therapeutic Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Lung Disease Therapeutic Drug Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Hospital Pharmacies
Figure 22. Product Picture of Retail Pharmacies
Figure 23. Product Picture of Online Pharmacies
Figure 24. Global Lung Disease Therapeutic Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Lung Disease Therapeutic Drug Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Lung Disease Therapeutic Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Lung Disease Therapeutic Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Lung Disease Therapeutic Drug Price by Application (2019-2030) & (US$/Unit)
Figure 29. North America Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Lung Disease Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Lung Disease Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Lung Disease Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Lung Disease Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Lung Disease Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Lung Disease Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Lung Disease Therapeutic Drug Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Lung Disease Therapeutic Drug Sales Volume (%), (2019-2030)
Figure 41. United States Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. China Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. China Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 59. India Lung Disease Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Lung Disease Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 61. India Lung Disease Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 62. Lung Disease Therapeutic Drug Industrial Chain
Figure 63. Lung Disease Therapeutic Drug Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
